<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The proto-oncogene c-met encodes a heterodimeric (alpha, beta) tyrosine kinase receptor which binds the hepatocyte growth factor (HGF) </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, overexpression of the Met/HGF receptor gene has been detected in fresh samples of <z:mp ids='MP_0002038'>carcinomas</z:mp> and in <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumor</z:e> cell lines but not in cell lines derived from human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Our analysis of 50 primary samples of human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and 23 hematopoietic cell lines revealed expression of <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein of the met/HGF receptor in 6 out of the 73 hematopoietic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>Four of the six samples positive for expression of the Met/HGF receptor gene were derived from patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, in one Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line and in one <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), expression of the Met/HGF receptor gene was detected </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> unstimulated lymphocytes, granulocytes or monocytes we did not find expression of the Met/HGF receptor gene </plain></SENT>
<SENT sid="6" pm="."><plain>Upon stimulation with the <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> we detected a weak expression of Met/HGF receptor specific transcripts of 9.0 kb in peripheral blood mononuclear cells of a healthy donor </plain></SENT>
<SENT sid="7" pm="."><plain>Cytogenetic analyses of three of the four cell lines which express the Met/HGF receptor gene revealed structural or numerical abnormalities of the long arm of chromosome 7, where the Met/HGFR gene is located, in each of the three cell lines analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>In one of these cell lines (L540) the Met/HGFR gene is translocated to a marker chromosome </plain></SENT>
<SENT sid="9" pm="."><plain>Southern blot and pulsed field gel electrophoresis experiments did not show any rearrangement in a region of 600 kb around the Met/HGF receptor gene excluding an activation of Met/HGFR by a TPR/Met oncogenic rearrangement as described for <z:chebi fb="0" ids="21759">MNNG</z:chebi>-<z:chebi fb="2" ids="37859">HOS</z:chebi> cells and for some <z:e sem="disease" ids="C0038356" disease_type="Neoplastic Process" abbrv="">gastric tumors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Our data indicate that the Met/HGFR gene is deregulated in a few cases of human <z:hpo ids='HP_0001909'>leukemia</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> possibly by chromosomal rearrangements resulting in an overexpression of the <z:mpath ids='MPATH_458'>normal</z:mpath> Met/HGF receptor <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein without formation of a hybrid gene </plain></SENT>
</text></document>